SanDisk Corporation NASDAQ: SNDK moved down by 0.85% to close at $37.32 SNDK traded 9.12 million shares for the day. Its earning per share remained 4.51. SanDisk Corporation (SanDisk) is engaged in designing, developing and manufacturing data storage solutions in a range of form factors using the flash memory, controller and firmware technologies. The Company�s solutions include removable cards, embedded products, universal serial bus (USB) drives, digital media players, wafers and components. The removable card products are used in a range of consumer electronics devices, such as mobile phones, digital cameras, gaming devices and laptop computers. Its embedded flash products are used in mobile phones, navigation devices, gaming systems, imaging devices and computing platforms.
Xilinx, Inc. NASDAQ: XLNX moved down by 2.43% to close at $25.71 XLNX traded 8.58 million shares for the day. Its earning per share remained 1.73. Xilinx, Inc. (Xilinx) designs, develops and markets programmable platforms. These programmable platforms have components that include integrated circuits (ICs) in the form of programmable logic devices (PLDs); software design tools to program the PLDs; targeted reference designs; printed circuit boards, and intellectual property (IP) cores. In addition to its programmable platforms, Xilinx provides design services, customer training, field engineering and technical support.
Gilead Sciences, Inc. NASDAQ: GILD moved down by 0.75% to close at $35.75 GILD traded 8.46 million shares for the day. Its earning per share remained 3.30. Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company that discovers, develops and commercializes therapeutics. Gilead Sciences, Inc. (Gilead) has operations in North America, Europe and Australia. The Company�s products include Truvada, Atripla, Viread, Emtriva, Hepsera, AmBisome, Letairis, Ranexa, Vistide and Cayston. Gilead Sciences, Inc. (Gilead) has sales operations, with marketing subsidiaries in Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, the Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, Turkey, the United Kingdom and the United States. Gilead Sciences, Inc. (Gilead) sells and distributes Truvada, Viread, Emtriva, Hepsera and AmBisome in Asia, Australia, Europe, Latin America, the Middle East and New Zealand, through its commercial teams, third party distributors or partners.
No comments:
Post a Comment